Trial intelligence / Profile preview

Anti-inflammatory Effect of Desloratadine and Levocetirizine in Allergic Rhinitis

NCT02507635Phase 4Completed

Sponsor
Iuliu Hațieganu University of Medicine and Pharmacy
Start
Feb 2009
Primary completion
Nov 2011
Modality
Small Molecules
01

Overview

A Phase 4 trial of desloratadine, levocetirizine in allergic rhinitis (AR), sponsored by Iuliu Hațieganu University of Medicine and Pharmacy. Started Feb 2009; status: completed.

02

Drugs

desloratadinelevocetirizine
03

Conditions

allergic rhinitis (AR)

Beyond the preview

Go deeper on NCT02507635.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02507635.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call